1492 related articles for article (PubMed ID: 8826661)
1. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center.
Mihalov ML; Gattuso P; Abraham K; Holmes EW; Reddy V
Clin Transplant; 1996 Jun; 10(3):248-55. PubMed ID: 8826661
[TBL] [Abstract][Full Text] [Related]
2. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
[TBL] [Abstract][Full Text] [Related]
3. Aggressive cutaneous malignancies following cardiothoracic transplantation: the Australian experience.
Veness MJ; Quinn DI; Ong CS; Keogh AM; Macdonald PS; Cooper SG; Morgan GW
Cancer; 1999 Apr; 85(8):1758-64. PubMed ID: 10223570
[TBL] [Abstract][Full Text] [Related]
4. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
Bakker NA; van Imhoff GW; Verschuuren EA; van Son WJ; Homan van der Heide JJ; Veeger NJ; Kluin PM; Kluin-Nelemans HC
Clin Transplant; 2005 Jun; 19(3):327-34. PubMed ID: 15877793
[TBL] [Abstract][Full Text] [Related]
5. Transmission of donor cancer into cardiothoracic transplant recipients.
Buell JF; Trofe J; Hanaway MJ; Lo A; Rosengard B; Rilo H; Alloway R; Beebe T; First MR; Woodle ES
Surgery; 2001 Oct; 130(4):660-6; discussion 666-8. PubMed ID: 11602897
[TBL] [Abstract][Full Text] [Related]
6. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
7. Dermatopathology of skin cancer in solid organ transplant recipients.
Stoff B; Salisbury C; Parker D; O'Reilly Zwald F
Transplant Rev (Orlando); 2010 Oct; 24(4):172-89. PubMed ID: 20709518
[TBL] [Abstract][Full Text] [Related]
8. De novo malignances in pediatric organ transplant recipients.
Penn I
Pediatr Transplant; 1998 Feb; 2(1):56-63. PubMed ID: 10084762
[TBL] [Abstract][Full Text] [Related]
9. Head and neck cancer in cardiothoracic transplant recipients.
Pollard JD; Hanasono MM; Mikulec AA; Le QT; Terris DJ
Laryngoscope; 2000 Aug; 110(8):1257-61. PubMed ID: 10942122
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinomas developing in solid organ transplant recipients: clinicopathologic study of 176 cases.
Kanitakis J; Alhaj-Ibrahim L; Euvrard S; Claudy A
Arch Dermatol; 2003 Sep; 139(9):1133-7. PubMed ID: 12975154
[TBL] [Abstract][Full Text] [Related]
11. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
12. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations.
Walker RC; Paya CV; Marshall WF; Strickler JG; Wiesner RH; Velosa JA; Habermann TM; Daly RC; McGregor CG
J Heart Lung Transplant; 1995; 14(2):214-21. PubMed ID: 7779838
[TBL] [Abstract][Full Text] [Related]
13. Trends in invasive disease due to Candida species following heart and lung transplantation.
Schaenman JM; Rosso F; Austin JM; Baron EJ; Gamberg P; Miller J; Oyer PE; Robbins RC; Montoya JG
Transpl Infect Dis; 2009 Apr; 11(2):112-21. PubMed ID: 19254327
[TBL] [Abstract][Full Text] [Related]
14. Malignancy in pediatric transplant recipients.
Buell JF; Gross TG; Thomas MJ; Neff G; Muthiah C; Alloway R; Ryckman FC; Tiao GM; Woodle ES
Semin Pediatr Surg; 2006 Aug; 15(3):179-87. PubMed ID: 16818139
[TBL] [Abstract][Full Text] [Related]
15. Low incidence of malignancy in heart-transplant recipients in Taiwan: an update and comparison with kidney-transplant recipients.
Hsu RB; Chang CI; Tsai MK; Lee PH; Chou NK; Chi NH; Wang SS; Chu SH
Eur J Cardiothorac Surg; 2010 May; 37(5):1117-21. PubMed ID: 20045346
[TBL] [Abstract][Full Text] [Related]
16. Incidence of malignancies in heart and/or lung transplant recipients: a single-institution experience.
Roithmaier S; Haydon AM; Loi S; Esmore D; Griffiths A; Bergin P; Williams TJ; Schwarz MA
J Heart Lung Transplant; 2007 Aug; 26(8):845-9. PubMed ID: 17692790
[TBL] [Abstract][Full Text] [Related]
17. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
[TBL] [Abstract][Full Text] [Related]
18. A population-based study of skin cancer incidence and prevalence in renal transplant recipients.
Moloney FJ; Comber H; O'Lorcain P; O'Kelly P; Conlon PJ; Murphy GM
Br J Dermatol; 2006 Mar; 154(3):498-504. PubMed ID: 16445782
[TBL] [Abstract][Full Text] [Related]
19. Prevention of non-melanoma skin cancer in organ transplant patients by regular use of a sunscreen: a 24 months, prospective, case-control study.
Ulrich C; Jürgensen JS; Degen A; Hackethal M; Ulrich M; Patel MJ; Eberle J; Terhorst D; Sterry W; Stockfleth E
Br J Dermatol; 2009 Nov; 161 Suppl 3():78-84. PubMed ID: 19775361
[TBL] [Abstract][Full Text] [Related]
20. Malignancies associated with renal transplantation.
Penn I
Urology; 1977 Jul; 10(1 Suppl):57-63. PubMed ID: 329521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
